Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its own once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) ...

Daiichi pays out Merck $170M to create lung cancer T-cell engager contract

.Merck &amp Co. has actually promptly recouped several of the costs of its own Javelin Therapeutics ...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin performed a springtime tidy of its own pipeline in April, the firm has chosen that i...

Eisai plants molecular adhesive SEED along with $1.5 B biobucks deal

.Large Pharmas stay caught to the idea of molecular glue degraders. The current provider to see a ch...

Life scientific research credit rating company reveals with $600M

.A new global lifestyle scientific research credit rating agency, nicknamed Symbiotic Financing, has...

BMS ditches TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another big bet coming from the Caforio age, terminating a p...

Nuvation standstills BET prevention after considering period 1 information

.After looking at period 1 record, Nuvation Bio has actually determined to stop deal with its one-ti...

' Professional intuitiveness' led FDA specialists to back Zevra's rare disease med

.Zevra Therapies' rare illness medicine appears to be on the path to approval this fall after obtain...

Pfizer takes $230M reached after axing fell short DMD genetics treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has gone a $230 million...

AC Immune views 'landmark' possible in Alzheimer's medication records

.After more than two decades of focus on neurodegenerative health conditions, Swiss biotech AC Immun...